Imatinib Gleevec | Community Health

Imatinib Gleevec is a groundbreaking medication used to treat various types of cancer, including chronic myelogenous leukemia (CML) and acute lymphocytic leukemia (ALL). Developed by [[novartis|Novartis]], it has been a game-changer in the field of oncology. Imatinib works by inhibiting specific tyrosine kinases, such as [[bcr-abl|Bcr-Abl]], which are involved in the growth and proliferation of cancer cells. This targeted approach has led to significant improvements in patient outcomes and has paved the way for further research into personalized medicine.